tejalbele-2024 - Tumblr blog

[tejalbele-2024]

3D Printing in Healthcare Market Value to Cross $5.8 Billion by 2030

The global 3D printing in healthcare market has witnessed dynamic growth in the recent years, owing to rapid technological advancements, increase in investments in R&D activities, and rapid expansion of customer base. 

[tejalbele-2024]

Vital signs devices monitoring deals with measurement of vital parameters, such as respiratory rate, blood pressure, temperature, and pulse to assess health conditions of a patient.

[tejalbele-2024]

Healthcare IT Market study especially analyses the impact of the Covid-19 outbreak on Healthcare IT, covering the supply chain analysis, impact assessment to the market size growth rate in several scenarios, and the measures to be undertaken by companies in response to the COVID-19 epidemic.

[tejalbele-2024]

Sports Medicine Devices Market Worth Observing Growth $12.73 Bn, Globally, by 2025 at 7.3% CAGR

The growth of the global sports medicine market is driven by increase in demand for sports medicines, owing to rise in incidence of sports-associated injuries.

Rise in incidence of sports-related injuries, supportive government initiatives, and increase in awareness about physical fitness are anticipated to boost the growth.”

— Allied Market Research

The report offers an extensive analysis of the changing trends, key market segments, drivers and opportunities, competitive landscape, top investment pockets among others. According to the report, the global sports medicine devices market accrued $7.17 billion in 2017 and is expected to reach $12.73 billion by 2025, growing at a CAGR of 7.3% from 2018 to 2025.

Rise in incidence of sports-related injuries, increase in awareness about physical fitness, and supportive government initiatives drive the growth of the industry. However, dearth of skilled professionals and lack of guidance on appropriate administration of sports medicines hinder the market growth. On the other hand, surge in demand for minimally invasive surgeries would create new opportunities for the market players in near future.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐭: https://www.alliedmarketresearch.com/request-sample/515

𝐁𝐨𝐝𝐲 𝐫𝐞𝐜𝐨𝐧𝐬𝐭𝐫𝐮𝐜𝐭𝐢𝐨𝐧 & 𝐫𝐞𝐩𝐚𝐢𝐫 𝐬𝐞𝐠𝐦𝐞𝐧𝐭 𝐭𝐨 𝐥𝐞𝐚𝐝 𝐭𝐡𝐫𝐨𝐮𝐠𝐡𝐨𝐮𝐭 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝

The body reconstruction & repair segment contributed more than one-third of the total market share in 2017 and is expected to continue its dominance throughout the forecast period. This is due to the rise in demand for surgical equipment in body reconstruction & repair procedures.

However, the body monitoring & evaluation segment would grow at the fastest CAGR of 9.9% from 2018 to 2025, owing to increase in inclination of people toward latest body monitoring and evaluation devices. The other segments analyzed in the study include orthopedic devices, body support & recovery, and accessories.

𝐊𝐧𝐞𝐞 𝐢𝐧𝐣𝐮𝐫𝐲 𝐬𝐞𝐠𝐦𝐞𝐧𝐭 𝐭𝐨 𝐫𝐞𝐦𝐚𝐢𝐧 𝐥𝐮𝐜𝐫𝐚𝐭𝐢𝐯𝐞 𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝟐𝟎𝟐𝟓

The knee injury segment accounted for about one-fourth of the total market share in 2017 and will maintain its lion's share throughout the forecast period. This segment would register the fastest CAGR of 8.6% from 2018 to 2025. As knee injury is one of the most common injuries a sportsperson is prone to, this segment offers lucrative prospects for the market during the forecast period. The other applications analyzed in the study include hand wrist injury, shoulder injury, ankle foot injury, arm elbow injury, back spine injury, and hip groin injury.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐄𝐧𝐪𝐮𝐢𝐫𝐲: https://www.alliedmarketresearch.com/purchase-enquiry/515

𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐭𝐨 𝐝𝐨𝐦𝐢𝐧𝐚𝐭𝐞 𝐢𝐧 𝐭𝐞𝐫𝐦𝐬 𝐨𝐟 𝐫𝐞𝐯𝐞𝐧𝐮𝐞 𝐛𝐲 𝟐𝟎𝟐𝟓

North America contributed nearly half of the total market share in 2017, owing to early adoption of advanced sports medicine devices in the region. This segment will remain dominant throughout the forecast period. However, Asia-Pacific would grow at the fastest CAGR of 12.2% from 2018 to 2025, owing to the rapidly changing healthcare infrastructure in developing nations including India and China, rise in awareness among people regarding fitness, and significant increase in the number of athletes.

𝐓𝐨𝐫𝐜𝐡𝐛𝐞𝐚𝐫𝐞𝐫𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭

The report analyzes key market players namely, Smith & Nephew Plc, Johnson & Johnson (Depuy Mitek), Stryker Corporation, Conmed Corporation, Arthrex, Inc., Breg, Inc., Zimmer Biomet Holdings, Inc., DJO Global, Inc., Mueller Sports Medicine, Inc., and Wright Medical Group N.V. These players have adopted various strategies such as mergers & acquisitions, partnerships, expansions, collaborations, joint ventures, and others to attain a strong foothold in the industry.

𝐀𝐜𝐜𝐞𝐬𝐬 𝐊𝐍𝐎𝐖𝐋𝐄𝐃𝐆𝐄 𝐓𝐑𝐄𝐄 (𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐨𝐧-𝐝𝐞𝐦𝐚𝐧𝐝, 𝐬𝐮𝐛𝐬𝐜𝐫𝐢𝐩𝐭𝐢𝐨𝐧-𝐛𝐚𝐬𝐞𝐝 𝐩𝐫𝐢𝐜𝐢𝐧𝐠 𝐦𝐨𝐝𝐞𝐥) 𝐚𝐭: https://www.alliedmarketresearch.com/knowledgetree

Knowledge tree is a cloud-based intelligence platform that offers more than 2,000 selective, off-the-shelf reports on niche markets to enable our clients gain deep insights on the latest trends, dynamic technologies, and emerging application areas.

𝐒𝐢𝐦𝐢𝐥𝐚𝐫 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:

Orthopedic Devices Market Single-arm Medical Pendant Market

𝐀𝐛𝐨𝐮𝐭 𝐀𝐥𝐥𝐢𝐞𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

[tejalbele-2024]

Animal Vaccines Market Worth Observing Growth $15.20 Bn, Globally, by 2030 at 5.2% CAGR: AMR

Growth in demand for pet insurance and rise in prevalence of animal diseases drive the growth of the global animal vaccines market.

These vaccines are effective over traditionally developed vaccines in preventing infections. Thus, this factor is anticipated to boost the demand of animal vaccines in near future. quote”

— Allied Market Research

Allied Market Research published a report, titled, "Animal Vaccines Market by Type (Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Recombinant Vaccines, and DNA Vaccines) and Animal Type (Companion Animal, Livestock Animal, and Aquaculture): Global Opportunity Analysis and Industry Forecast, 2021–2030." According to the report, the global animal vaccines market generated $9.09 billion in 2020, and is expected to reach $15.20 billion by 2030, growing at a CAGR of 5.2% from 2020 to 2030.

Vaccines help develop naturally acquired immunity by stimulating the immune system with the help of either non-pathogenic organisms or by their immunogenic components. Animal vaccines are essential to increase the welfare of the animal and reduce the monetary loss of their owners. These consist of attenuated and subunit vaccines and are useful in the prevention of diseases through their mode of action. Animal vaccines are eco-friendly products that help reduce the use of antibiotics and risk of drug-resistant microorganisms.

𝐅𝐨𝐫 𝐑𝐢𝐠𝐡𝐭 𝐏𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞 𝐚𝐧𝐝 𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐭: https://www.alliedmarketresearch.com/request-sample/1988

𝐏𝐫𝐢𝐦𝐞 𝐝𝐞𝐭𝐞𝐫𝐦𝐢𝐧𝐚𝐧𝐭𝐬 𝐨𝐟 𝐠𝐫𝐨𝐰𝐭𝐡

Growth in demand for pet insurance, rise in prevalence of animal diseases, surge in expenditure for animal health, and increase in ownership of companion animal drive the growth of the global animal vaccines market. However, highly competitive meat and milk prices and adverse impact of veterinary vaccines on human and animal health hinders the market growth. On the other hand, advancement in vaccine product and rise in demand for hybrid animal create new opportunities in coming years.

𝐂𝐨𝐯𝐢𝐝-𝟏𝟗 𝐒𝐜𝐞𝐧𝐚𝐫𝐢𝐨

The emergence of covid-19 affected the animal vaccine market negatively. The veterinary organizations across the globe have recommended limiting animal patient care to acutely ill animals and emergencies. The lockdown measures have led to rescheduling of annual checkup exams and elective vaccination procedures. The supply of animal vaccination witnessed disruptions to certain point. However, the manufacturers ensured proper supply of animal vaccinations. The attenuated vaccines segment to maintain its dominant position during the forecast period

Based on product, the attenuated vaccines a segment held the highest market share in 2020, accounting for nearly two-fifths of the global animal vaccines market, and is expected to maintain its dominant position during the forecast period. This is attributed to availability of advanced technology for specific mutations/deletions in genes of the virus. However, the DNA vaccines segment is estimated to witness the highest CAGR of 8.10% from 2020 to 2030, owing to increase in prevalence of animal diseases, and its easy manipulation as compared to traditional vaccines.

The animal vaccines market is segmented into companion animal, livestock animal, and aquaculture. The companion animal segment is further segmented into cats and dogs. The livestock animal segment is further classified into cattle, pigs, poultry, sheep, and others (goats, horses, asses, camel, and others). The companion animal segment is expected to be the fastest growing segment throughout the analysis period and accounted for almost one-third of the total share of the market in 2020.

𝐃𝐨 𝐘𝐨𝐮 𝐇𝐚𝐯𝐞 𝐀𝐧𝐲 𝐐𝐮𝐞𝐫𝐲 𝐎𝐫 𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐑𝐞𝐪𝐮𝐢𝐫𝐞𝐦𝐞𝐧𝐭? 𝐀𝐬𝐤 𝐭𝐨 𝐎𝐮𝐫 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐄𝐱𝐩𝐞𝐫𝐭: https://www.alliedmarketresearch.com/purchase-enquiry/1988

𝐓𝐡𝐞 𝐥𝐢𝐯𝐞𝐬𝐭𝐨𝐜𝐤 𝐬𝐞𝐠𝐦𝐞𝐧𝐭 𝐭𝐨 𝐦𝐚𝐢𝐧𝐭𝐚𝐢𝐧 𝐢𝐭𝐬 𝐥𝐞𝐚𝐝𝐞𝐫𝐬𝐡𝐢𝐩 𝐬𝐭𝐚𝐭𝐮𝐬 𝐛𝐚𝐬𝐞𝐝 𝐨𝐧 𝐫𝐞𝐯𝐞𝐧𝐮𝐞 𝐛𝐲 𝟐𝟎𝟑𝟎

Based on animal type, the livestock animal segment accounted for nearly than two-thirds of the global animal vaccines market in 2020, and is projected to maintain its leadership status based on revenue by 2030. Increase in the prevalence of various infectious diseases among livestock animals and surge in awareness related to importance of immunization. However, the companion animal segment is expected to portray the highest CAGR of 5.50% from 2020 to 2030. The increase in awareness regarding medical illnesses & ailments of companion animals and growth in animal healthcare expenditure worldwide drive the growth of the segment.

𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐭𝐨 𝐦𝐚𝐢𝐧𝐭𝐚𝐢𝐧 𝐢𝐭𝐬 𝐡𝐢𝐠𝐡𝐞𝐬𝐭 𝐜𝐨𝐧𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐭𝐡𝐫𝐨𝐮𝐠𝐡𝐨𝐮𝐭 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝

Based on region, North America held the majority share in 2020, with nearly two-fifths of the total share of the global animal vaccines market, and will maintain its highest contribution throughout the forecast period. This is due to established veterinary organizational structures and concern amongst people to ensure animal health. However, Asia-Pacific is expected to maintain the highest CAGR of 5.90% during the forecast period, owing to increase in need of protection of livestock from mass wipeouts due to epidemics, especially in countries such as India.

𝐋𝐞𝐚𝐝𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 𝐩𝐥𝐚𝐲𝐞𝐫𝐬

Merck & Co., Inc., Zoetis Inc., Ceva Santé Animale, Sanofi S.A., Romvac, Vaxxinova, Biovac, Merial, Boehringer Ingelheim GmbH, Anicon Labor GmbH

Animal vaccines are eco-friendly products that help reduce the use of antibiotics and risk of drug-resistant microorganisms. They help protect animal health by immunizing the animal from any particular disease. These vaccines are essential for animal well-being, production of food, and safety of public health. Animal vaccines is a component of a larger field of medicine called veterinary biologics (VB).

𝐀𝐛𝐨𝐮𝐭 𝐀𝐥𝐥𝐢𝐞𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

[tejalbele-2024]

Antipsychotic Drugs Market Expected to Reach $ 26,041.00 Million by 2030 - AMR

Antipsychotic is a class of medication used to treat psychosis, including hallucinations, delusions, paranoia, or disordered thought, schizophrenia, and bipolar disorder. It is also used to treat Alzheimer's and other memory-related diseases. Antipsychotic drugs act by controlling production of dopamine in the brain.

Major factors that contribute toward the antipsychotic drugs market growth include rise in funding by private & government organizations to mental health treatment and increase in service areas of mental disorder. Surge in awareness about the benefits associated with telehealth and tele-psychiatry, especially in developed countries, is resulting in key investments directed toward these platforms. However, rise in cost of mental health programs and substance abuse is expected to hamper the market growth. Conversely, unmet medical needs in emerging nations are expected to provide a lucrative opportunity in the market.

📚 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/request-sample/437

The global market for antipsychotic drugs is anticipated to witness positive growth trends, owing to strong increase in the prevalence of psychotic disorders. This increase in the number of patient pools across the globe is anticipated to drive the growth of the market. For instance, according to the Global Burden of Disease Study, there is an increasing disease burden due to schizophrenia globally, especially in middle-income countries and low-income countries.

According to the data published by Medscape in 2019, lifelong prevalence rate of bipolar disorder was estimated to be 0.3-1.5%. However, in recent years, the prevalence of the bipolar disorder has increased substantially. This has led several pharmaceutical companies to engage in R&D of antipsychotic medications, leading to new product launches. Such factors are expected to drive growth of the global antipsychotic drugs market during the forecast period

𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 𝐍𝐨𝐰 : https://www.alliedmarketresearch.com/antipsychotic-drugs-market/purchase-options

A substantial proportion of the global patient base suffers from psychotic disorders, including various types of schizophrenia, bipolar disorders, and unipolar depression or major depressive disorders. Efficiency of drugs used in the treatment of these psychotic disorders is of utmost importance. It has led to strong demand for safer and highly efficient drugs for treatment of psychotic disorders. According to the American Psychiatric Association (APA), in 2018, approximately 1 in 24 individuals are anticipated to suffer from serious mental disorders, including serious psychotic disorders. This increase in awareness, combined with introduction of new antipsychotic drugs based on innovative R&D, is expected to drive the market growth.

On the basis of therapeutic class, the global antipsychotic drugs market is divided into first-generation and second-generation. The second-generation segment was the major revenue contributor in 2020, and is anticipated to remain dominant during the forecast period. Long-acting injectable antipsychotic drugs have the efficacy of daily pills and eliminate the need to monitor drug intake of patients. Hence, the number of benefits attributed to this form of antipsychotic has led to a greater degree of product adoption.

𝐄𝐧𝐪𝐮𝐢𝐫𝐞 𝐁𝐞𝐟𝐨𝐫𝐞 𝐁𝐮𝐲𝐢𝐧𝐠 : https://www.alliedmarketresearch.com/purchase-enquiry/437

By application, the global antipsychotic drugs market is divided into schizophrenia, dementia, bipolar disorder, depression, and others. The schizophrenia segment dominated the market in 2020, and is anticipated to continue this trend during the forecast period. This is attributed to rapidly increase in incidences of schizophrenic disorders, owing to change in lifestyle.

Depending on distribution channel, the global antipsychotic drugs market is segregated into a hospital pharmacies, retail pharmacies, and online pharmacies. The retail pharmacies segment led the market in 2020, and is anticipated to maintain its lead during the forecast period.

North America was the largest shareholder in the global antipsychotic drugs market in 2020, owing to its well-established healthcare infrastructure, surge in adoption of mental healthcare services, increase in geriatric population, and rise in prevalence of mental diseases. However, Asia-Pacific is anticipated to register the highest CAGR during the forecast period, owing to increase in health awareness, development in healthcare infrastructure, and rise in number of hospitals equipped with advanced medical facilities.

🔘 𝐊𝐞𝐲 𝐅𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐎𝐟 𝐓𝐡𝐞 𝐒𝐭𝐮𝐝𝐲

✔️ By therapeutic class, the Second-generation segment was the highest contributor to the market in 2020. ✔️ By application, the schizophrenia segment was the highest contributor to the market in 2020. ✔️ By distribution channel, the retail pharmacies segment is projected to grow at a significant CAGR of 8.1% from 2021 to 2030. ✔️ By region, North America garnered largest revenue share in 2020, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭: David Correa 1209 Orange Street, Corporation Trust Center, Wilmington, New Castle, Delaware 19801 USA. USA/Canada (Toll Free): +1-800-792-5285 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1-800-792-5285 help@alliedmarketresearch.com Web: www.alliedmarketresearch.com Allied Market Research Blog: https://blog.alliedmarketresearch.com Follow Us on | Facebook | LinkedIn | YouTube |

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬 : Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

[tejalbele-2024]

Pain Management drugs Market valued at $71,431.85 million in 2019, and is projected to reach $91,649.16 million

The global pain management drugs market was valued at $71,431.85 million in 2019, and is projected to reach $91,649.16 | CAGR of 3.8% from 2020 to 2027.

PORTLAND, OREGON, UNITED STATES, February 1, 2024 /EINPresswire.com/ -- Pain is a disturbing sensory and emotional sensation that results from tissue damage or disease. In addition, different disorders may cause discomfort, such as multiple sclerosis, osteoarthritis, stomach ulcer, chronic arthritis, fibromyalgia, diabetic neuropathy, and cancer. The length of pain ranges from acute pain for short term to chronic pain for long term. Acute pain can be mild and lasts for only a moment or for weeks, or months. Chronic pain is caused by aged bone & joint conditions, nerve damage, or injury. A variety of drugs are used to manage pain resulting from inflammation in response to tissue damage, chemical agents/pathogens (nociceptive pain) or nerve damage (neuropathic pain). Most drugs act by binding to protein targets on cell membranes and affecting biochemical processes of the body.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/request-sample/404

Rise in geriatric population is the major factor that drives growth of the global pain management drugs market as aged people are more prone to suffer from joint pain and other chronic conditions. Moreover, surge in prevalence of chronic diseases, such as cancer, diabetic neuropathy, and osteoarthritis propels the market growth. Furthermore, rise in number of surgical procedures and rise in healthcare expenditure are expected to fuel growth of the pain management drugs market. However, drug exploitation, patent expiration of prescription pain medication drugs, and availability of substitutes such as pain relief devices restrain the market growth.

𝐃𝐫𝐮𝐠 𝐜𝐥𝐚𝐬𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭 𝐫𝐞𝐯𝐢𝐞𝐰 By drug class, the opioids segment was the largest contributor to the market in 2019, owing to high efficiency of opioids to relieve pain in major chronic conditions. The anesthetics segment is anticipated to possess highest growth rate during the forecast period.

𝐃𝐨 𝐘𝐨𝐮 𝐇𝐚𝐯𝐞 𝐀𝐧𝐲 𝐐𝐮𝐞𝐫𝐲 𝐎𝐫 𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐑𝐞𝐪𝐮𝐢𝐫𝐞𝐦𝐞𝐧𝐭? 𝐀𝐬𝐤 𝐭𝐨 𝐎𝐮𝐫 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐄𝐱𝐩𝐞𝐫𝐭: https://www.alliedmarketresearch.com/purchase-enquiry/404

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 ELI LILY AND COMPANY MERCK & CO. INC. PFIZER INC. ABBOTT LABORATORIES GLAXOSMITHKLINE PLC (GSK) MYLAN N.V. NOVARTIS INTERNATIONAL AG PURDUE PHARMA L.P. JOHNSON & JOHNSON ENDO HEALTH SOLUTIONS INC. (ENDO INTERNATIONAL PLC.)

𝐊𝐞𝐲 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬 𝐅𝐨𝐫 𝐒𝐭𝐚𝐤𝐞𝐡𝐨𝐥𝐝𝐞𝐫𝐬 The study provides an in-depth analysis of the global pain management drug market along with the current trends and future estimations to elucidate the imminent investment pockets. A comprehensive analysis of the factors that drive and restrict the pain management drugs market growth is provided in the report. The pain management drugs market forecast is studied from 2020 to 2027 Comprehensive quantitative analysis of the industry from 2019 to 2027 is provided to enable the stakeholders to capitalize on the prevailing market opportunities. Extensive analysis of the key segments of the industry helps to understand the application and products of pain management used across the globe. Key market players and their strategies have been analysed to understand the competitive outlook of the pain management drugs market.

𝐀𝐧𝐚𝐥𝐲𝐬𝐭 𝐑𝐞𝐯𝐢𝐞𝐰 The demand for pain management drugs has increased rapidly over recent years. Pain can be caused due to various reasons such as chronic diseases, cancer, and surgeries. Thus, these segments are the largest contributors to the market growth. Presence of large geriatric population base, rise in global prevalence of cancer, and availability of pipeline drugs that pose to be promising treatment options for patients with chronic diseases contribute to growth of the market.

However, patent expiration of major best-seller drugs such as pregabalin and duloxetine by Pfizer and Eli Lilly & Co., respectively, and availability of alternative therapies such as acupuncture, massage, and medical devices hamper the market growth.

Employment of pain management drugs is the highest in North America, owing to increase in adoption of these drugs, high prevalence of chronic diseases, and increase in disposable income of customers. In addition, presence of a large geriatric population and favorable regulatory & healthcare reforms such as the U.S. Patient Protection and Affordable Care Act of 2010 supplement the market growth.

Although the use of pain management drugs in Asia-Pacific and LAMEA is low, the adoption rate is expected to increase, owing to rise in disposable income and surge in incidences of chronic diseases. China and India are potential markets in Asia-Pacific. Moreover, increase in R&D investments, upsurge in healthcare expenditure, and rise in government funding & initiatives propel the market growth in Asia-Pacific.

[tejalbele-2024]

Artificial intelligence technologies are widely being employed by policymakers, and medical professionals to manage the outbreak effect and accelerate its early detection, prevention, response, recovery and to pace the research. 

[tejalbele-2024]

Pulmonary lesions are often characterized by hypoxia, pulmonary complications, and pulmonary edema. This condition causes inflammation or direct injury to the lungs. Symptoms include severe shortness of breath, high blood pressure, confusion, and extreme fatigue.

[tejalbele-2024]

Pulmonary lesions are often characterized by hypoxia, pulmonary complications, and pulmonary edema. This condition causes inflammation or direct injury to the lungs. Symptoms include severe shortness of breath, high blood pressure, confusion, and extreme fatigue.

[tejalbele-2024]

Healthcare IT includes the creation, development, design, and maintenance of information systems for the healthcare industry. The market is experiencing significant growth due to increase in demand for quality healthcare services and solutions, rise in acceptance of mHealth and telehealth practices, surge in demand for improved patient safety and patient care, rise in government initiative to promote HCIT, and increase in adoption of cloud technology in healthcare.